Barclays raised target for Manulife Financial stock from CAD 59.00 to CAD 61.00
Published on 10/09/2026 at 15:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Barclays raised its Manulife Financial price target from CAD 59.00 to CAD 61.00 on October 7, 2026.
- Manulife reported CAD 20.34 billion in second-quarter revenue and CAD 1.09 earnings per share.
- The stock was trading at EUR 37.48 at Lang & Schwarz on October 9, 2026, down 0.24 percent from EUR 37.57.
- Manulife's next estimated earnings date is November 4, 2026.
Manulife Financial (ISIN CA56501R1064) was trading at EUR 37.48 at Lang & Schwarz on October 9, 2026 at 3:30 p.m. CEST, down 0.24 percent versus the prior close of EUR 37.57. According to Markets Insider on October 7, 2026, Barclays raised its target for Manulife from CAD 59.00 to CAD 61.00 while keeping an Equal Weight rating.
Three events shaped the stock
On August 5, 2026, Manulife reported second-quarter revenue of CAD 20.34 billion and earnings per share of CAD 1.09, according to MarketBeat. The revenue figure matches the latest standardized quarterly data, while the earnings figure provides the clearest benchmark for the insurer's operating performance.
On October 1, 2026, Manulife closed a long-term-care reinsurance transaction transferring biometric risk on policies with CAD 3.20 billion of reserves to Munich Re Life US, as reported in the Financial Times company announcement.
Barclays then lifted its target on October 7, 2026, from CAD 59.00 to CAD 61.00. The change came in a third-quarter earnings preview that cited asset-management tailwinds, favorable mortality and stabilizing spreads, according to Markets Insider.
What does the reinsurance deal change?
The CAD 3.20 billion reserve transfer is the most tangible balance-sheet event in the sequence. It shifts biometric risk to a specialist reinsurer and supports Manulife's stated capital-efficiency strategy, but it also makes execution by the reinsurance partner a material consideration for future results, as the Financial Times announcement explains.
Next date for Manulife results
MarketBeat lists November 4, 2026 as Manulife's estimated next earnings date. That report will give investors a fresh comparison with the CAD 20.34 billion of second-quarter revenue and the CAD 1.09 earnings per share reported for the prior period.
Stock sits below its yearly high
The euro reference price of EUR 37.48 at Lang & Schwarz was 0.24 percent below the prior close of EUR 37.57 on October 9, 2026. The same-day German quote context showed a 52-week range of EUR 26.01 to EUR 39.18, placing the price EUR 1.70 below the high, or 4.34 percent.
The further course of trading is shown by the continuously updated real-time quote of Manulife Financial stock.
Manulife Financial stock facts
- Company: Manulife Financial Corporation
- ISIN: CA56501R1064
- WKN: 926517
- Ticker: MFC
- Primary exchange: Toronto Stock Exchange
- Price Lang & Schwarz (as of October 9, 2026, 3:30 p.m. CEST): EUR 37.48
- Change versus prior close: minus 0.24 percent
- Prior close Lang & Schwarz (October 8, 2026): EUR 37.57
- Market capitalization: USD 70.2 billion (as of October 9, 2026)
- 52-week range: EUR 26.01-EUR 39.18 (as of October 9, 2026)
- Sector / Industry: Financial Services / Insurance - Life
- Index membership: S&P/TSX Composite Index
- Next earnings date: November 4, 2026
Market context: Market report S&P/TSX Composite.
